We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+5.43%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$122B
AUM Growth
+$19.9B
Cap. Flow
+$13.8B
Cap. Flow %
11.34%
Top 10 Hldgs %
17.25%
Holding
5,042
New
422
Increased
2,412
Reduced
1,537
Closed
397

Sector Composition

Rank Sector Weight
1 Financials 9.9%
2 Energy 8.92%
3 Technology 8.45%
4 Healthcare 7.84%
5 Industrials 6.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MERU
4451
DELISTED
MERU NETWORKS INC COM STK (DE)
MERU
$40K ﹤0.01%
10,882
-206
-2% -$812
EDMC
4452
PUT
DELISTED
EDUCATION MGMT CORP NEW COM STK (PA)
EDMC
$39K ﹤0.01%
+22,900
New +$61.7K
TGS icon
4453
Transportadora de Gas del Sur
TGS
$4.48B
$38K ﹤0.01%
+14,331
New +$37.3K
EDMC
4454
DELISTED
EDUCATION MGMT CORP NEW COM STK (PA)
EDMC
$38K ﹤0.01%
22,715
-39,123
-63% -$105K
RVLT
4455
DELISTED
Revolution Lighting Technologies, Inc. - Class A
RVLT
$36K ﹤0.01%
1,569
-981
-38% -$25.3K
FREE
4456
DELISTED
FREESEAS INC SHS NEW APR 2016 (MHL)
FREE
0
CREG
4457
DELISTED
Smart Powerr
CREG
$33K ﹤0.01%
2
+1
+100% +$29.6K
VXRT
4458
DELISTED
Vaxart
VXRT
$33K ﹤0.01%
1,076
-3,841
-78% -$160K
KBIO
4459
DELISTED
KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE)
KBIO
$33K ﹤0.01%
1,833
+176
+11% +$3.01K
CDXS icon
4460
Codexis
CDXS
$159M
$32K ﹤0.01%
21,893
+1,387
+7% +$2.2K
MBOT icon
4461
Microbot Medical
MBOT
$111M
$32K ﹤0.01%
10
AVL
4462
DELISTED
Avalon Rare Metals, Inc. Ordinary Shares (Canada)
AVL
$31K ﹤0.01%
66,196
ZLCS
4463
DELISTED
ZALICUS INC COM NEW
ZLCS
$31K ﹤0.01%
25,432
-279
-1% -$313
TEUM
4464
DELISTED
Pareteum Corporation
TEUM
$30K ﹤0.01%
1,258
-2,984
-70% -$72.8K
NKBS
4465
DELISTED
NEWTEK BUSINESS SERVICES, INC.
NKBS
$30K ﹤0.01%
+11,095
New +$30K
HTM
4466
DELISTED
U.S. Geothermal Inc.
HTM
$29K ﹤0.01%
+8,161
New +$33.8K
LOCM
4467
DELISTED
LOCAL CORP COM STK (DE)
LOCM
$29K ﹤0.01%
+13,754
New +$25.6K
BODY
4468
DELISTED
BODY CENTRAL CORP COM STK
BODY
$28K ﹤0.01%
32,007
+20,068
+168% +$18.7K
EVRY
4469
DELISTED
EVERYWARE GLOBAL INC COM STK (DE)
EVRY
$27K ﹤0.01%
20,386
+2,989
+17% +$6.45K
CSCI
4470
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$26K ﹤0.01%
2
-1
-33% -$11.2K
CETC
4471
DELISTED
Hongli Clean Energy Technologies Corp. Common Stock
CETC
$26K ﹤0.01%
+2,121
New +$23.1K
RMGN
4472
DELISTED
RMG Networks Holding Corporation
RMGN
$25K ﹤0.01%
+2,750
New +$29.8K
BIOA.WS
4473
CALL
DELISTED
BioAmber Inc.
BIOA.WS
$25K ﹤0.01%
10,000
ECTE
4474
DELISTED
ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE)
ECTE
$24K ﹤0.01%
10,488
+106
+1% +$263
MTSN
4475
DELISTED
MATTSON TECHNOLOGY INC
MTSN
$24K ﹤0.01%
10,962
-150,712
-93% -$316K

Similar funds

Credit Suisse's Q2 2014 Portfolio in Review

As of Q2 2014, Credit Suisse held 5,042 positions worth $122B, up 19% from $102B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Credit Suisse deployed $13.8B of net new capital in Q2 2014, opening 422 new positions and adding to 2,412 existing holdings. Its largest new stake was Alphabet (Google) Class C: 33,383,082 shares worth $963M.

By sector, the portfolio is most concentrated in Financials at 9.9% of assets, down from 10% a quarter earlier, followed by Energy and Technology.

On the sell side, the largest reduction was iShares China Large-Cap ETF, an estimated $476M trimmed.

  • Credit Suisse's largest Q2 2014 buy was Alphabet (Google) Class C: 33,383,082 shares worth $963M.
  • Credit Suisse added most to State Street SPDR S&P 500 ETF Trust in Q2 2014, an estimated $892M increase.
  • Credit Suisse's biggest Q2 2014 reduction was iShares China Large-Cap ETF, cutting an estimated $476M.
  • Credit Suisse fully exited Weatherford International plc in Q2 2014, selling an estimated $129M.
  • Credit Suisse's ten largest holdings make up 17% of its $122B portfolio in Q2 2014.
  • Credit Suisse opened 422 new positions and closed 397 in Q2 2014.
  • Credit Suisse's portfolio value rose 19% quarter-over-quarter to $122B.

Based on Credit Suisse's 13F filing for Q2 2014, filed 11 Aug 2014.